Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge
Opsoclonus-myoclonus syndrome (OMS) is a neurological non-fatal disease that usually responds to immunotherapies. However, the real challenge is to counteract the high frequency of relapses and long-term developmental sequelae. Since the OMS is extremely rare, a common consensus regarding therapeuti...
Saved in:
Main Authors: | Marina Auconi, Laura Papetti, Claudia Ruscitto, Michela Ada Noris Ferilli, Fabiana Ursitti, Giorgia Sforza, Federico Vigevano, Massimiliano Valeriani |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a339353d51e94e9a8289d93d2cec185c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Breast cancer-associated opsoclonus-myoclonus syndrome: a case report
by: Aikaterini Kostoglou, et al.
Published: (2021) -
Multifocal myoclonus as a presentation of levetiracetam toxicity
by: Mei Bou Nasif, et al.
Published: (2021) -
Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review
by: Samuela Tarantino, et al.
Published: (2021) -
Clinical Characteristics and Outcomes of Children With Extracorporeal Membrane Oxygenation in a Developing Country: An 11-Year Single-Center Experience
by: Wirapatra Iamwat, et al.
Published: (2021) -
Evaluating the Functional Outcomes and the Quality of Life for Pediatric Patients with Osteogenesis Imperfecta after Fracture Treatment with Intramedullary Rodding
by: Alexandru Herdea, et al.
Published: (2021)